Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Bode

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Hospital Practice (1995)|May 18, 2013
Efficacy and safety of canagliflozin treatment in older subjects with type 2 diabetes mellitus: a randomized trialBruce Bode, Kaj Stenlöf, Daniel Sullivan, et al.
Annals of Medicine|June 29, 2021
Leveraging advances in diabetes technologies in primary care: a narrative reviewBruce Bode, Aaron King, David Russell-Jones, et al.
Archives of Disease in Childhood|June 20, 2022
Celebration of a century of insulin therapy in children with type 1 diabetesAlan D Rogol, Lori M Laffel, Bruce Bode, et al.
Journal of Diabetes Science and Technology|September 19, 2017
Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 DiabetesEric Zijlstra, Marek Demissie, Tina Graungaard, et al.
Journal of Clinical Pharmacology|May 23, 2015
Preserved pharmacokinetic exposure and distinct glycemic effects of insulin degludec and liraglutide in IDegLira, a fixed-ratio combination therapyChristoph Kapitza, Bruce Bode, Steen Hvass Ingwersen, et al.
Diabetes Care|September 26, 2019
Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 DiabetesDavid Klonoff, Bruce Bode, Nathan Cohen, et al.
Journal of the American Geriatrics Society|March 23, 2016
Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled AnalysisAlan J Sinclair, Bruce Bode, Stewart Harris, et al.
Journal of Diabetes Science and Technology|May 12, 2020
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United StatesBruce Bode, Valerie Garrett, Jordan Messler, et al.
European Journal of Internal Medicine|January 16, 2007
Basal insulin or premix analogue therapy in type 2 diabetes patientsPhilip R Raskin, Priscilla A Hollander, Andrew Lewin, et al.
Diabetes Technology & Therapeutics|July 16, 2021
Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop SystemBruce Bode, Anders Carlson, Rong Liu, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Hospital Practice (1995)|May 18, 2013
Efficacy and safety of canagliflozin treatment in older subjects with type 2 diabetes mellitus: a randomized trialBruce Bode, Kaj Stenlöf, Daniel Sullivan, et al.
Annals of Medicine|June 29, 2021
Leveraging advances in diabetes technologies in primary care: a narrative reviewBruce Bode, Aaron King, David Russell-Jones, et al.
Archives of Disease in Childhood|June 20, 2022
Celebration of a century of insulin therapy in children with type 1 diabetesAlan D Rogol, Lori M Laffel, Bruce Bode, et al.
Journal of Diabetes Science and Technology|September 19, 2017
Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 DiabetesEric Zijlstra, Marek Demissie, Tina Graungaard, et al.
Journal of Clinical Pharmacology|May 23, 2015
Preserved pharmacokinetic exposure and distinct glycemic effects of insulin degludec and liraglutide in IDegLira, a fixed-ratio combination therapyChristoph Kapitza, Bruce Bode, Steen Hvass Ingwersen, et al.
Diabetes Care|September 26, 2019
Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 DiabetesDavid Klonoff, Bruce Bode, Nathan Cohen, et al.
Journal of the American Geriatrics Society|March 23, 2016
Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled AnalysisAlan J Sinclair, Bruce Bode, Stewart Harris, et al.
Journal of Diabetes Science and Technology|May 12, 2020
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United StatesBruce Bode, Valerie Garrett, Jordan Messler, et al.
European Journal of Internal Medicine|January 16, 2007
Basal insulin or premix analogue therapy in type 2 diabetes patientsPhilip R Raskin, Priscilla A Hollander, Andrew Lewin, et al.
Diabetes Technology & Therapeutics|July 16, 2021
Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop SystemBruce Bode, Anders Carlson, Rong Liu, et al.
Pageof 7